EPLERENONE
- Product NDC
- 31722-050
- 11-digit product format
- 317220050
- Labeler code
- 31722
- Product ID
- 31722-050_fe285cf1-1e78-943b-e053-6394a90a760d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- EPLERENONE
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Camber Pharmaceuticals, Inc.
- Application
- ANDA213812
- Marketing category
- ANDA
- Marketing start
- 2023-06-02
- Substance
- EPLERENONE
- Active strength
- 50 mg/1
- Pharmacologic classes
- Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- EPLERENONE
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| EPLERENONE | 50 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 6995V82D0B |
| Rxcui | 351256, 351257 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 31722-050-30 | EPLERENONE | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | | 1 |
| 31722-050-90 | EPLERENONE | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 31722-050 | EPLERENONE (EPLERENONE) TABLET, FILM COATED [CAMBER PHARMACEUTICALS, INC.] | 1 | Current NDC, 2 package rows | 20230616_25a1c77c-7008-4b07-af14-5522a282783a.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 31722-050-30 | 31722005030 | 30 TABLET, FILM COATED in 1 BOTTLE (31722-050-30) | 2023-06-02 | No | No | Current |
| 31722-050-90 | 31722005090 | 90 TABLET, FILM COATED in 1 BOTTLE (31722-050-90) | 2023-06-02 | No | No | Current |